The Holy Grail: highlighting the need for equitable access to dementia treatments and clinical trials
Summary: In the last 5 years significant progress has been made in potential dementia treatments, yet many of these treatments come with significant burdens on the healthcare system that may limit access to treatment and care for patients. Often patients in remote and rural regions and those in low...
Saved in:
Main Authors: | Rebekah M. Ahmed, Olivier Piguet, Catherine J. Mummery, Sharon L. Naismith, Muireann Irish |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-02-01
|
Series: | The Lancet Regional Health. Western Pacific |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S266660652500029X |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Knowledge and attitudes towards Alzheimer’s disease and related dementias among Nigerian medical and nursing students: a comparative study
by: Tobi Olajide, et al.
Published: (2025-02-01) -
Making Dementia Matter Through Sound
by: Marjolein Gysels, et al.
Published: (2024-03-01) -
Exploring cognitive and neuroimaging profiles of dementia subtypes of individuals with dementia in the Democratic Republic of Congo
by: Jean Ikanga, et al.
Published: (2025-02-01) -
The effectiveness of dance interventions on the cognitive functioning of people with dementia or cognitive impairment: A systematic review
by: Dauda Salihu, et al.
Published: (2024-11-01) -
Fighting Alzheimer’s with Movement: The Role of Physical Activity in Disease Management
by: Agnieszka Kosińska, et al.
Published: (2025-02-01)